PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Racecadotril - Diarrhoea
PAD Profile : Racecadotril - Diarrhoea
Brand Names Include :
Hidrasec
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
03 June 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
05 September 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Racecadotril is not recommended by the PCN for the treatment of acute diarrhoea in adults and children.
See the Racecadotril Policy statement below for further details
05 March 2014
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The PCN did not support the routine prescribing of Racecadotril and consider it as BLACK on the traffic light system
Associated BNF Codes
01. Gastro-Intestinal System
01.04.03. Enkephalinase inhibitors